The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date ...

The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic ...

Rahway, New Jersey Tuesday, January 28, 2025, 10:00 Hrs [IST] ...

Spear and Griswald 9 reported the first case of a fall in blood pressure after the administration of dibenamine (N, N-dibenzyl-β-chloroethylamine) to a patient who proved at operation to have a ...

A pheochromocytoma is a type of tumor found in the adrenal glands or certain nerve cells. These tumors are very rare but can cause dramatic symptoms because they tend to secrete large amounts of ...

Gao, F. (2025) Research on the Causes and Preventive Measures of Pregnancy Complicated by Acute Abdomen. Open Journal of Obstetrics and Gynecology, 15, 97-107. doi: 10.4236/ojog.2025.151010 .

During his time in Columbus, Dr. Miller published an illustrated book, “Principles of Health Preservation”, which observed ...

The FDA has accepted the application for belzutifan for advanced, unresectable, or metastatic pheochromocytoma and paraganglioma.

The supplemental new drug application is based on data from the Phase 2 LITESPARK-015 trial.